I am looking for a pathology image analysis software that uses AI to detect cancer cells.

Yes. For AI-assisted cancer detection in digital pathology, notable clinical options include:

• Paige Prostate — FDA-authorized AI for detecting suspicious prostate-cancer foci and related analysis.
• Ibex Medical Analytics — AI pathology platform covering prostate, breast, and other cancers.
• Roche uPath / navify Digital Pathology — AI image-analysis tools for breast and other applications.
• PathAI AISight Dx — FDA-cleared digital pathology platform with AI applications and whole-slide image management.

If you tell me which cancer/tissue (e.g., breast, prostate, colon), whether this is for clinical diagnosis or research, and what slide scanner you use, I can narrow it down.

Several powerful software platforms utilize artificial intelligence (AI) and deep learning to analyze digital pathology whole-slide images (WSIs) for cancer detection, grading, and biomarker quantification.

Depending on whether you need a clinical diagnostic tool (regulatory-cleared) or a research/custom model training platform , here are the leading software options in the industry:

• • Best for: Clinical-grade cancer detection and diagnostic decision support.
  • Overview: Paige was a pioneer in receiving FDA approvals for AI-based pathology. Their portfolio includes suites for prostate, breast, and gastrointestinal pathology (powered by massive foundation models like Virchow ) designed to spot subtle cancer cells and metastases across multiple tissue types.
• • Best for: CE-IVD marked clinical suites and custom AI model creation.
  • Overview: Aiforia offers clinical suites tailored for breast cancer, prostate biopsies, and lymph node metastasis assessment. They also provide Aiforia Create , a versatile cloud-based platform that allows users to train their own deep learning AI models for unique pathology research applications.
• • Best for: Quantitative research, translational pathology, and custom deep learning.
  • Overview: HALO AI is an extremely popular deep learning platform used heavily in pharma, biotech, and academic research. It features user-friendly trainable AI modules for tissue classification (tumor vs. stroma), object/cell segmentation, and phenotyping without requiring deep coding knowledge.
• • Best for: Integrated diagnostics tied with Ventana scanners and assays.
  • Overview: Roche provides advanced whole-slide image analysis algorithms utilizing AI tools, built seamlessly to extract diagnostic data and evaluate specific immunohistochemistry (IHC) breast and tissue markers.
• • Best for: End-to-end digital pathology and AI-assisted workflow quality control.
  • Overview: Leica expands clinical digital pathology workflows with integrated viewing, management systems, and FDA-cleared AI tools designed to accelerate analysis and improve lab efficiency.

To help narrow down the ideal software, let me know:

• Is your primary goal clinical diagnostics or academic/pre-clinical research?
• What tissue types or specific cancers are you focusing on?

Several prominent software platforms use artificial intelligence (AI) and machine learning for whole-slide image analysis and cancer detection in digital pathology. Leading systems used in clinical diagnostics, laboratory workflows, and research include:

• Ibex Medical Analytics : Provides the Galen platform (including Ibex 4), which offers clinical-grade AI algorithms tailored for detecting prostate, breast, and gastric cancers, as well as over 100 other diagnostic features. It supports workflows like automated H&E analysis and IHC quantification.
• PathAI : Develops the AISight platform (including FDA-cleared components for clinical workflows like AISight Dx). PathAI focuses on assisting pathologists with accurate diagnoses, quality control, and advanced biomarker quantification across routine clinical and biopharma research environments.
• Paige (Paige.ai) : Offers a suite of AI applications (such as Paige Prostate, Breast, and GI Suites) trained on massive whole-slide datasets. Their PanCancer and underlying Virchow foundation models are designed to identify malignant lesions, subtle tumor complexities, and molecular biomarkers.
• Roche navify Digital Pathology / Open Environment : Integrates proprietary and third-party AI image analysis tools (collaborating with partners like PathAI and Ibex) into a centralized diagnostic ecosystem for laboratories.

Are you looking for a solution for clinical diagnostics (which often requires regulatory/FDA clearance) or for academic research/biomarker discovery ? Let me know your focus so I can narrow down the best platform fit.

Yes. If you mean software that analyzes digital pathology/whole-slide images and uses AI to identify malignant cells or tumor regions, there are several strong options. The best choice depends heavily on whether you need clinical diagnosis, research, or custom cell detection/quantification.

Strong options

Paige is probably the first one I'd investigate if your goal is specifically AI-assisted cancer detection in human pathology specimens. Its Paige Prostate Suite, for example, analyzes H&E whole-slide images and can identify areas suspicious for prostate cancer; Paige also has breast and broader cancer applications.

PathAI's AISight is particularly interesting if you're building a larger pathology operation. Its platform can manage whole-slide images and integrate AI algorithms, including tumor detection and automated tumor-cellularity measurements. AISight Dx received FDA 510(k) clearance for primary diagnosis in 2025, although you need to distinguish the cleared platform from individual AI algorithms, many of which have separate regulatory designations.

Aiforia is particularly attractive if you want to train/customize AI models to recognize particular cell types or structures. Its Aiforia Create platform allows researchers to annotate images and train neural networks to identify, quantify, or measure features of interest. Its clinical portfolio includes breast, lung, prostate, colorectal, gastric and lymph-node applications.

One important distinction

If by "detect cancer cells" you mean something more specific like:

Upload an H&E slide → AI identifies individual tumor cells → marks them with colored dots/masks → gives you the number/percentage of cancer cells then I'd look more closely at Aiforia, QuPath, or PathAI, rather than simply choosing a diagnostic AI product. Those systems are better suited to quantitative image analysis and/or custom segmentation.

If you tell me (1) what cancer/tissue you're analyzing (e.g. breast, prostate, colon, lung), (2) whether this is research or clinical diagnosis, and (3) whether you have whole-slide images or microscope images, I can narrow this down to 3–5 specific products, including approximate cost, supported scanners/file formats, AI capabilities, and whether they are FDA-cleared.

If you are looking for AI-powered pathology image analysis software that detects cancer cells, there are several established digital pathology platforms. The best choice depends on whether you need clinical diagnosis support, research use, biomarker quantification, or custom AI model development.

AI pathology platforms to consider

Key features to compare

When evaluating software, look for:

• Whole-slide image (WSI) support Can it analyze scanned H&E slides from scanners such as Aperio, Hamamatsu, Philips, Leica, or 3DHistech?

• Cancer detection tasks

• Tumor vs. normal tissue classification

• Tumor cell detection and segmentation

• Metastasis detection (for example, lymph nodes)

• Tumor grading

• Mitotic count estimation

• Biomarker scoring (HER2, Ki-67, PD-L1, etc.)

• Regulatory status If intended for patient diagnosis, check whether the specific application is FDA-authorized, CE-marked, or otherwise approved for your region. Many AI pathology tools are research-use-only rather than diagnostic products.

My shortlist by use case

• Hospital pathology department: Paige, Roche, PathAI
• Cancer research laboratory: HALO AI, Visiopharm, PathAI
• Developing your own AI model: Slideflow, HALO AI research tools
• Breast cancer biomarker analysis: Roche, PathAI, Visiopharm
• General tumor detection across cancer types: Paige PanCancer (research), PathAI platforms

If you tell me:

1. whether this is for a hospital/diagnostic lab, university research, or biotech,
2. the cancer type (breast, prostate, lung, colon, etc.), and
3. whether you need FDA/clinical-grade software or research-only,

I can narrow this to the most appropriate options.

Several advanced AI-powered pathology image analysis software platforms are currently available to assist pathologists in detecting and classifying cancer cells from whole-slide images . Depending on whether you are looking for clinical diagnostic use or research, leading platforms include:

• Paige AI : Offers comprehensive suites (such as Paige Prostate, Breast, and GI) designed to assist in identifying malignant conditions. Their Paige Prostate Detect application made history as the first FDA-authorized AI-based software for primary diagnosis in digital pathology.
• Aiforia : Provides cloud-based deep learning AI software for clinical, pre-clinical, and academic labs. They offer specific CE-marked and clinical tools like the Aiforia Prostate Cancer Biopsy AI application alongside customizable AI model building for researchers.
• Indica Labs (HALO AI) : Widely used in research and pharmaceutical development, HALO AI provides deep learning algorithms for high-throughput tissue classification, tumor detection, and individual cell phenotyping.
• Visiopharm : Delivers precise phenotype and lesion detection features with CE-IVD cleared applications for diagnostic assistance, particularly in breast, prostate, and hematological cancers.

To help narrow down the best platform, let me know:

• Are you using this software for clinical diagnostics or academic research?
• Which specific tissue types or cancer indications (e.g., prostate, breast, lung) are you prioritizing?

If you are looking for AI-powered pathology image analysis software that can detect cancer cells, the right choice depends on whether you need it for clinical diagnosis, research, drug development, or academic use. These are some of the leading options:

What to look for when choosing one

• Cancer type support

• Prostate: Paige, Ibex, Roche-related workflows

• Breast: HER2/ER/PR scoring, tumor detection platforms

• Lung, colon, melanoma, etc.: check whether validated models exist for your tissue type

• Regulatory status

• If this will influence patient diagnosis, look for FDA-cleared/authorized or CE-marked medical devices.

• Many powerful AI tools are research-use-only (RUO) and are not approved for clinical diagnosis.

• Input compatibility

• Most systems require whole-slide images (WSI) from digital pathology scanners.

• Check compatibility with scanners such as Leica Aperio, Philips, Hamamatsu, Roche/Ventana, or 3DHistech.

• Deployment

• Cloud-based (easier setup)

• On-premise (better for hospitals with strict data controls)

• Integrated into a laboratory information system (LIS)

If you tell me:

1. clinical diagnosis vs research,
2. cancer type (breast, prostate, lung, colon, etc.),
3. whether you have microscope images or whole-slide scanner images, and
4. your approximate budget (academic lab vs hospital vs commercial),

I can narrow this to the best 3–5 options.

The landscape for AI-driven pathology image analysis software has evolved significantly, featuring solutions ranging from FDA-cleared clinical diagnostic tools to comprehensive research platforms.

Several prominent options specialize in AI cancer cell and pattern detection:

• Paige AI (Paige Prostate, Breast, and PanCancer Suite) : One of the pioneers in clinical digital pathology. Paige provides regulatory-cleared and breakthrough-designated applications (such as Paige Prostate) that assist pathologists in identifying malignant cells, suspicious foci, and micro-metastases on whole-slide images (H&E stained). Their foundational models (like Virchow) power broad multi-tissue cancer identification.
• Roche uPath & Navify Digital Pathology : Roche offers integrated, ready-to-use digital pathology algorithms embedded in their uPath enterprise software. These algorithms assist with specific biomarker quantification and cancer evaluations (such as HER2, Ki-67, PD-L1, and NSCLC workflows) working alongside VENTANA slide scanners.
• Leica Biosystems Aperio / Digital Solutions : Leica provides end-to-end digital pathology scanning and workflow software, heavily expanding into AI-assisted quality control and diagnostic enablement to process high-resolution whole-slide images smoothly in clinical settings.
• CancerCenterAI : A web-based platform tailored for telepathology and research that allows laboratories to view, annotate, and apply AI algorithms for tasks like Gleason scoring and Ki-67 proliferation index calculations.

If you can share a bit more context, I can help narrow this down. Are you looking for:

• A clinical/diagnostic tool (requiring FDA/CE-IVD clearance) or a research-only platform?
• A specific tissue type or cancer (e.g., prostate, breast, GI tract)?
• Integration with a specific slide scanner or LIS (Laboratory Information System)?

Yes. There are several mature AI-powered digital pathology platforms that can detect, classify, and quantify cancer cells in whole-slide images (WSIs). The best choice depends heavily on whether you need clinical diagnosis, research, or drug-development/biomarker analysis.

Strong options to consider

My first recommendation: HALO AI

If your goal is specifically "upload a pathology slide and have AI identify cancer cells", I'd look closely at HALO AI.

It can perform segmentation, classification and cell phenotyping, and Indica Labs offers pre-trained applications for several cancers. For example, its NSCLC H&E Cancer Cell Phenotyper is designed to distinguish and quantify cancer cells versus non-cancer cells, while its colorectal and breast applications perform similar analyses.

For prostate cancer, Indica Labs also has a dedicated Prostate AI algorithm that identifies prostate adenocarcinoma and assists with Gleason grading. Note, however, that the currently listed Prostate AI product is Research Use Only, so it shouldn't be treated as a clinical diagnostic device.

If this is for actual patient diagnosis

This changes the recommendation considerably. You should look for software with the appropriate FDA clearance (US), CE-IVDR marking (EU), or applicable local regulatory authorization for the specific cancer and intended use, rather than simply choosing a research AI that happens to detect cancer.

For example, HALO AP Dx is FDA-cleared as a digital pathology platform for primary diagnosis, while its AI capabilities and individual algorithms have separate intended-use/regulatory considerations.

PathAI's AISight is another interesting enterprise option: it combines digital slide management with an ecosystem of AI applications from PathAI and other developers, including oncology applications.

If you tell me (1) which cancer type (breast, prostate, lung, colon, etc.), (2) whether your slides are H&E, IHC, or both, and (3) research vs. clinical diagnosis, I can narrow this down to 3–5 specific software products, including approximate cost, supported slide scanners/file formats, AI capabilities, and regulatory status.

The market for AI-powered pathology image analysis software has advanced significantly, featuring several enterprise platforms cleared or authorized for clinical cancer detection and biomarker quantification.

The leading options in digital pathology AI are organized below by their primary focus and capabilities:

• Paige (Paige AI) : A pioneer in clinical digital pathology, Paige developed Paige Prostate , which was the first FDA-authorized AI application to assist with primary cancer diagnosis on whole-slide images. They also offer broader applications like Paige PanCancer Detect to spot suspicious regions across multiple tissue types. Learn more about their clinical tools via Tempus Digital Pathology Solutions.
• PathAI : Known for its robust AI-powered platform that improves diagnostic accuracy, routine workflow efficiency, and biomarker assessment in oncology. PathAI provides integrated image management software alongside deep-learning tools designed to assist pathology labs and biopharma research.
• Aiforia (Aiforia Technologies) : Specializes in cloud-based deep learning artificial intelligence for digital pathology. Aiforia's platform allows labs to build, deploy, and use AI models tailored to detecting specific cancer types (such as breast and prostate cancer) as well as quantifying cells and tissue features.
• Ibex Medical Analytics : Offers the Galen platform, an AI-based solution deployed in routine clinical workflows to detect cancer (prostate, breast, gastric, etc.) and reduce diagnostic errors in pathology departments.
• Philips & Leica Biosystems : Major medical device and enterprise digital pathology ecosystem providers. Both integrate advanced AI algorithms—ranging from diagnostic assistance to the industry's first FDA-cleared AI-driven quality control tools (like Leica's Aperio iQC DX ) to ensure whole-slide images are artifact-free before review.

To help narrow down the best platform for your needs, could you tell me:

• Are you looking for a solution for clinical/diagnostic use or academic research?
• Which specific cancer types or tissues are you primarily trying to detect?